Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. (Q40354450)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2006

Language	Label	Description	Also known as
English	Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.	scientific article published on March 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Charles Stiller

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Aengus O'Marcaigh

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Anupama Rao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Brenda E Gibson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Siebold S N de Graaf

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ian M Hann

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Keith Wheatley

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

David K H Webb

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

0 references

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

132

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

576-583

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445830%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

The management of neoplastic disorders of haematopoiesis in children with Down's syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Onco

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

Epidemiology of leukemia in children with Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05906.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40354450&oldid=1503095860"